Welcome to Swan NeuroTech

We are a start-up advancing nerve regeneration

Advanced Biomaterials for Nerve Regeneration

Our mission

We are dedicated to developing innovative technologies for nerve repair and regeneration

our target

Peripheral nerve injuries are common results of trauma, cancer, and chronic disease, leading to $20B in annual US health care costs

our solution

We have developed biodegradable drug-delivery implants to regenerate injured nerves

Swan NeuroTech is developing a portfolio of biomaterial-based drug delivery technologies

nerve graft  conduits

Tunable polymer chemistry for improved mechanical properties

controlled drug delivery

Polymer microsphere technology for optimized drug release kinetics

manufacturing
innovation

Additive manufacturing using proprietary polymer dipping technology

biodegradable materials

Long duration implants with safe degradation products

Meet our Team

Get to know our Management Team and Advisors

Heather Callahan, PhD, JD, EMBA

Chief Executive Officer

Heather is an entrepreneur experienced in early start-up leadership who has business development, intellectual property, product development, and operational expertise.  She has previous law firm, investment, biotech, university, and hospital experience focused on developing products to treat unmet medical needs.

Kacey Marra, PhD

Founder & Chief Scientific Officer

Kacey is an scientific innovator in regenerative medicine, drug-delivery, and polymer science. She is a tenured Professor in the Departments of Plastic Surgery and Bioengineering at the University of Pittsburgh.

Advisors

Anthony Windebank, MD

Clinical Advisor

Kia Washington, MD

Clinical Advisor

Steve Winowich

Business Advisor

Arta Kelmendi-Doko, MD, PhD

Scientific Advisor

Pamela Vidmar, MBA

Business Advisor

Contact Info

Let’s Chat

Get in touch with us to learn more!